// App-Quantinova.ai

TPS262 : A single-blinded, multicenter, randomized controlled trial to evaluate NeuroSAFE robotic-assisted radical prostatectomy (RARP) versus standard robotic-assisted radical prostatectomy (RARP) in men with localized prostate cancer: NeuroSAFE PROOF—Trial in progress.

Researchers

Presenter

  • Eoin Dinneen

Principal Investigators

  • Jack Grierson

  • Aiman Haider

  • Alex Freeman

  • Jonathan Aning

  • Rajendra Persad

  • Neil Oakley

  • Imran Ahmad

  • Lorenzo Dutto

  • Greg Shaw

Medical Centers

  • Kings College London, London, United Kingdom

  • NCRI, London, United Kingdom

  • University College London Hospitals NHS Trust, London, United Kingdom

  • North Bristol NHS Trust, Bristol, United Kingdom

  • University of Bristol, Bristol, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

  • Queen Elizabeth University Hospital, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Multinational

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • NCT03317990

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved